Effects of Different Types of Hsp90 Inhibitors in Pancreatic and Colorectal Cancer Cell Lines

被引：0
|
作者：
Mayor-Lopez, L. [1 ]
De Torre, C. [1 ]
Tristante-Barrenechea, E. [1 ]
Carrasco-Garcia, E. [2 ]
Garcia-Morales, P. [3 ]
Saceda, M. [3 ]
Carballo, F. [1 ]
Martinez-Lacaci, I. [1 ]
机构：
[1] Hosp Univ Virgen de la Arrixaca, Unidad AECC Invest Traslac Canc, Murcia, Spain
[2] Univ Miguel Hernandez, Elche, Spain
[3] Hosp Gen Univ Elche, Unidad Invest, Elche, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71581-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
962
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [1] Combination therapies with HSP90 inhibitors against colorectal cancer
    Kryeziu, Kushtrim
    Bruun, Janie
    Guren, Tormod K.
    Sveen, Anita
    Lothe, Ragnhild A.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (02): : 240 - 247
  • [2] Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
    Simonas Daunys
    Daumantas Matulis
    Vilma Petrikaitė
    Scientific Reports, 9
  • [3] Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
    Daunys, Simonas
    Matulis, Daumantas
    Petrikaite, Vilma
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Hsp90 inhibitors target addiction to mutant oncoproteins in colorectal cancer
    Clarke, P. A.
    Welsh, L.
    Valenti, M.
    Eccles, S.
    Workman, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 47 - 47
  • [5] Study of Hsp90α and Hsp90β role in virus replication using cell lines with Hsp90 gene knockouts
    Bieganowski, Pawel
    Dalidowska, Iga
    Gazi, Olga
    Guzowska, Magdalena
    Przybylski, Maciej
    VIRUS GENES, 2025,
  • [6] Antiangiogenic effects associated with the inhibition of HSP90 in colorectal cancer
    Mahaseth, Hemchandra
    Nagaraju, Ganji Purnachandra
    Diaz, Roberto
    Taliaferro-Smith, LaTonia D.
    Landry, Jerome C.
    Saba, Nabil F.
    El-Rayes, Bassel F.
    CANCER RESEARCH, 2012, 72
  • [7] HSP90 as a therapeutic target in colorectal cancer
    Nagaraju, Ganji Purnachandra
    Willingham, Field F.
    Woods, Kevin E.
    Sullivan, Patrick
    Landry, Jerome C.
    Diaz, Roberto
    El-Rayes, Bassel F.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Combination of Hsp90 inhibitors and MEK inhibitors abrogates ERK activation in pancreatic cancer cells
    Zhang, Tao
    Li, Yanyan
    Sun, Duxin
    CANCER RESEARCH, 2009, 69
  • [9] Synergistic inhibition of cancer cell viability and suppression of HIFI a by CDK4 inhibitors and HSP90 inhibitors across cancer types
    Zhao, Shuai
    Zhou, Lanlan
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] EGCG inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cells
    Li, Yanyan
    Zhang, Tao
    Schwartz, Steven
    Sun, Duxin
    CANCER RESEARCH, 2009, 69
12345